858
M. Alyari, M. M. Baradarani, A. Afghan, and J. A. Joule
Vol 51
n
max/cmÀ1: 3055, 2971, 2932, 2873, 1557, 1500, 950, 753, 686; 1H
25.92, 56.02, 124.03, 126.15, 127.38, 130.21, 130.64, 141.72,
156.16, 168.98, 177.94; MS (EI): m/z 285 (M+), 270, 229, 192,
16
NMR (CDCl3): d 1.71 (s, 6H), 2.61 (s, 3H), 7.05 (d, J = 8.1 Hz, 1H),
7.11 (d, J= 8.1 Hz, 1H), 7.37 (t, J= 8.1 Hz, 1H), 7.52 (t, J=8.1Hz,
2H), 7.80 (d, J= 8.1Hz, 2H), 8.33 (s, 1H), 8.61 (s, 1H); 13C NMR
(CDCl3): d 16.58, 21.34, 55.51, 117.68, 119.54, 125.99, 126.21,
127.37, 127.50, 128.74, 129.61, 130.54, 139.50, 140.85, 141.04,
166, 115; Found: M+ 285.1030, C16H ClN3 requires M 285.1033.
35
General procedure for synthesis of (18a,b, 19, 20). Urea,
thiourea, or cyanoacetamide (0.626 mmol) was dissolved in hot
EtOH (8 mL, 95%) then dialdehyde 15 (0.57mmol) and piperidine
(0.11 g, 0.12 mL, and 1.25mmol) were added with stirring and the
mixture was heated at reflux for 24 h. The mixture was cooled,
filtered, and the precipitate washed with aqueous ethanol.
177.88; MS (EI): m/z 335 (M+), 115, 77 (100), 51; Found: M+
35
18
335.1186, C20H ClN3 requires M 335.1189.
4-Chloro-2-(1-(4-chlorophenyl)-1H-pyrazol-4-yl)-3,3,7-trimethyl-
3H-indole (16c). (Yield 89%); mp 181–183ꢀC; FT-IR (KBr) nmax
/
5-(4-Chloro-3,3,7-trimethyl-3H-indol-2-yl)pyrimidin-2(1H)-
cmÀ1: 3065, 2971, 2930, 1577, 1499, 1457, 1228, 951, 831; 1H NMR
(CDCl3): d 1.91 (s, 6H), 2.91 (s, 3H), 7.23 (d, J= 8.1 Hz, 1H), 7.27 (d,
J=8.1Hz, 1H), 7.50 (d, J=8.7Hz, 2H), 7.91 (d, J= 8.7 Hz, 2H), 8.44
(s, 1H), 11.28 (s, 1H); 13C NMR (CDCl3): d 18.61, 22.46, 54.28,
111.07, 121.03, 126.88, 127.35, 129.21, 130.06, 132.62, 134.57,
one (18a). (Yield 79%); mp 300ꢀC (dec); FT-IR (KBr) nmax
/
cmÀ1: 3140, 3024, 2922, 2855, 1727, 1669, 1553, 1461, 1237; 1H
NMR (DMSO-d6): d 1.54 (s, 6H), 2.45 (s, 3H), 7.08 (d,
J = 8.1Hz, 1H), 7.15 (d, J = 8.1 Hz, 1H), 8.97 (s, 2H), 12.51 (bs,
1H, NH); 13C NMR (DMSO-d6): d 16.49, 20.58, 55.38, 101.28,
136.08, 136.66, 137.14, 142.22, 179.43; MS (EI): m/z 369 (M+), 191,
109.44, 125.52, 126.51, 129.06, 131.15, 141.73, 153.28, 155.95,
14
35
178.09; Found: M+ 287.0824, C15H ClN3O requires M 287.0825.
35
154, 128, 111, 75; Found: M+ 369.0801, C20H Cl2N3 requires M
17
5-(4-Chloro-3,3,7-trimethyl-3H-indol-2-yl)pyrimidine-2(1H)-
369.0800.
thione (18b). (Yield 81%); mp 286–287ꢀC (dec); FT-IR (KBr)
n
4-Chloro-2-(1-(3-chloro-2-methylphenyl)-1H-pyrazol-4-yl)-
3,3,7-trimethyl-3H-indole (16d). (Yield 90%); mp 185–187ꢀC;
FT-IR (KBr) nmax/cmÀ1: 3060, 2971, 2927, 1561, 1496, 1453, 955,
max/cmÀ1: 3145, 2977, 2924, 2632, 2548, 1627, 1460, 1240, 982,
788; 1H NMR (DMSO-d6): d 1.58 (s, 6H), 2.48 (s, 3H), 7.13 (d,
1
J = 8.1 Hz, 1H), 7.20 (d, J = 8.1 Hz, 1H), 9.43 (s, 2H), 13.14 (bs,
840; H NMR (CDCl3): d 1.71 (s, 6H), 2.31 (s, 3H), 2.61 (s, 3H),
35
14
1H, NH); Anal. Calcd. for C15H ClN3S: C, 59.30; H, 4.64; N,
7.08 (d, J= 8.1 Hz, 1H), 7.10 (d, J= 8.1 Hz, 1H), 7.29–7.35
(m, 3H), 7.44 (s, 1H), 8.35 (s, 1H); 13C NMR (CDCl3): d 16.49,
17.80, 21.34, 55.51, 117.06, 126.09, 126.19, 126.49, 128.78,
129.02, 130.50, 131.07, 132.01, 132.12, 132.55, 139.94, 140.56,
13.83% Found: C, 59.16; H, 4.59; N, 13.77%.
3-((5-(4-Chloro-3,3,7-trimethyl-3H-indol-2-yl)pyrimidin-2-
yl)imino)-2-(4-chloro-1,3-dihydro-3,3,7-trimethyl-2H-indol-2-
ylidene)propanal (19a and 19b). To a solution of guanidine
hydrochloride (0.06 g, 0.63 mmol) in hot EtOH (8 mL, 95%),
dialdehyde 11 (0.33 g, 1.25 mmol) and piperidine (0.05 g,
0.63 mmol) were added with stirring, then the mixture was
heated at reflux for 24 h. The mixture was cooled and filtered
and the precipitate was washed with ethanol (95%) to give 19a
141.00,177.77; Found: M+ 383.0958, C21H Cl2N3 requires M
35
19
383.0956.
4-Chloro-2-(1-(2,4-dimethylphenyl)-1H-pyrazol-4-yl)-3,3,7-
trimethyl-3H-indole (16e). (Yield 91%); mp 188–190ꢀC; FT-
IR (KBr) nmax/cmÀ1: 3066, 2973, 2925, 1634, 1566, 1489, 1313,
1
1233, 733; H NMR (CDCl3): d 1.69 (s, 9H), 2.30 (s, 3H), 2.58
or 19b (0.51 g, 77%); mp 248–249ꢀC; FT-IR (KBr) nmax/cmÀ1
:
(s, 3H), 7.05 (d, J = 7.5Hz, 1H), 7.10 (d, J = 7.5 Hz, 1H), 7.30 (d,
J = 7.8 Hz, 1H), 7.36 (d, J = 7.8 Hz,1H), 7.44 (s, 1H), 8.28 (s, 1H),
8.34 (s, 1H); 13C NMR (CDCl3): d 16.45, 17.80, 21.30, 55.56,
117.20, 125.89, 126.12, 126.18, 128.83, 129.00, 130.45, 131.02,
132.00, 132.15, 132.54, 139.98, 140.51, 141.15, 154.02, 177.76;
3160, 2975, 2929, 2869, 1678, 1618, 1569, 1461, 1294, 1183;
1H NMR (CDCl3): d 1.75 (s, 6H), 1.82 (s, 6H), 2.61 (s, 3H),
2.64 (s, 3H), 7.08–7.16 (m, 4H), 8.94 (s, 1H, H-C═N, due to
isomer 19a or 19b), 9.37 (s, 2H, pyrimidine ring protons), 9.63
(s, 1H, CHO), 14.40 (s, 1H, NH); 13C NMR (CDCl3): d 16.36,
16.62, 18.30, 20.64, 55.81, 57.25, 111.88, 122.66, 126.13,
126.22, 126.78, 127.23, 127.84, 130.04, 130.66, 140.80, 141.68,
151.34, 153.49, 153.49, 157.54, 158.27, 177.46, 182.70, 188.67;
Found: M+ 363.1502, C22H ClN3 requires M 363.1502.
35
22
4-Chloro-2-(1-(2,5-dichlorophenyl)-1H-pyrazol-4-yl)-3,3,7-
trimethyl-3H-indole (16f). (Yield 89%); mp 161–162ꢀC; FT-
IR (KBr) nmax/cmÀ1: 3065,2959, 2870, 2577, 2530, 1617, 1581,
1520, 1471, 1349, 1226, 1144; 1H NMR (CDCl3): d 1.69 (s, 6H),
2.59 (s, 3H), 7.05 (d, J = 8.1 Hz, 1H), 7.01 (d, J = 8.1 Hz), 7.37
(d, J = 8.7Hz, 1H), 7.51 (d, J = 8.7 Hz, 1H), 7.73 (s, 1H), 8.39
(s, 1H), 8.55 (s, 1H); 13C NMR (CDCl3): d 16.54, 21.30, 55.52,
117.28, 126.20, 127.66, 128.42, 128.94, 129.56, 130.55, 131.69,
Found: M+ 531.1593, C29H Cl2N5O requires M 531.1593.
35
27
5-(4-Chloro-3,3,7-trimethyl-3H-indol-2-yl)-2-oxo-1,2-dihydropyridine-
3-carbonitrile (20). (Yield 81%); mp 300ꢀC (dec.); FT-IR (KBr)
n
max/cmÀ1: 3167, 3085, 2995, 2923, 2231, 1663, 1552, 1551,
1
1455, 1226; H NMR (DMSO-d6): d 1.56 (s, 6H), 2.46 (s, 3H),
7.10 (d, J = 7.8, 1H), 7.18 (d, J = 7.8, 1H), 8.44 (s, 1H), 8.81 (s,
1H), 13.06 (bs, 1H); 13C NMR (DMSO-d6): d 16.46, 20.56,
55.27, 104.90, 111.32, 116.16, 125.48, 126.71, 129.21, 131.15,
133.64, 138.18, 141.05, 141.33, 177.42; MS (EI): m/z 403 (M+)
35
271, 255, 220, 182, 162; Found: M+ 403.0409, C20H Cl3N3
16
requires M 403.0410.
4-Chloro-3,3,7-trimethyl-2-(2-methylpyrimidin-5-yl)-3H-indole
141.97, 142.69, 147.98, 152.94, 159.92, 178.03; Found: M+
35
14
311.0821, C17H ClN3O requires M 311.0825.
(17).
A mixture of 2-(4-chloro-1,3-dihydro-3,3,7-trimethyl-
2H-indol-2-ylidene)propanedial 15 (0.2 g, 0.76 mmol) and
acetamidine hydrochloride (0.078 g, 0.83 mmol) in DMF
(10 mL) was heated at reflux for 3 days. After complete
conversion (TLC), the reaction mixture was allowed to cool
overnight. Filtration furnished compound 17 (0.18 g, 83%).
Recrystallization from DMF gave pure product, mp 144–
146ꢀC; FT-IR (KBr) nmax/cmÀ1: 3055, 2979, 2926, 1582,
Acknowledgments. The authors are grateful to the University of
Urmia for financial support of this work.
REFERENCES AND NOTES
[1] Fischer, O.; Müller, A.; Vilsmeier, A. J Prakt Chem 1925, 109, 69.
[2] Vilsmeier, A.; Haack, A. Ber Dtsch Chem Ges 1927, 60B, 119.
[3] Jugie, G.; Smith, J. A. S.; Marin, G. J. J Chem Soc Perkin
Trans 2 1975, 925.
1
1552, 1450, 1374, 991, 802; H NMR (CDCl3): d 1.73 (s, 6H),
2.62 (s, 3H), 2.87 (s, 3H), 7.13 (d, J = 8.1 Hz, 1H), 7.20 (d,
J = 8.1 Hz, 1H),9.38 (s, 2H); 13C NMR (CDCl3): 16.35, 20.46,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet